---
title: "Latent-Y: The Autonomous AI Agent for Drug Design at Scale"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280759916.md"
description: "Latent Labs has introduced Latent-Y, an AI agent that can create therapeutic antibodies quickly from text prompts. This technology uses Latent-X2, the company's advanced model for antibody and peptide design, to accelerate the process significantly. By leveraging Latent-Y, researchers can now achieve in hours what would typically take weeks with expert input. This innovation enables structural drug design without needing specialized infrastructure, broadening access for all researchers. Latent Labs is partnering with selected organizations to provide access to Latent-Y, which promises to revolutionize drug discovery."
datetime: "2026-03-27T08:56:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280759916.md)
  - [en](https://longbridge.com/en/news/280759916.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280759916.md)
---

# Latent-Y: The Autonomous AI Agent for Drug Design at Scale

Latent Labs has introduced Latent-Y, an AI agent that can create therapeutic antibodies quickly from text prompts. This technology uses Latent-X2, the company's advanced model for antibody and peptide design, to accelerate the process significantly. By leveraging Latent-Y, researchers can now achieve in hours what would typically take weeks with expert input. This innovation enables structural drug design without needing specialized infrastructure, broadening access for all researchers. Latent Labs is partnering with selected organizations to provide access to Latent-Y, which promises to revolutionize drug discovery.

### Related Stocks

- [MDLB.US](https://longbridge.com/en/quote/MDLB.US.md)

## Related News & Research

- [Lupin bets big on India's GLP-1 market & respiratory drugs](https://longbridge.com/en/news/287021542.md)
- [Rigetti shares drop after Q1 growth fails to ease concerns](https://longbridge.com/en/news/286968241.md)
- [Karbon-X and Evertrak Sign Letter of Intent to Advance Infrastructure-Linked Plastic Waste Reduction Credit Initiative | KARX Stock News](https://longbridge.com/en/news/286950981.md)
- [00:45 ETAraceli Biosciences Launches Endeavor® Live Cell for Ultra-High-Throughput Kinetic Imaging in AI-Driven Drug Discovery](https://longbridge.com/en/news/287006505.md)
- [Eli Lilly (LLY) Is the Face of the Obesity Boom. Has the Market Already Priced It In?](https://longbridge.com/en/news/286727957.md)